Clinical Trial Update: A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA) [Phase 3]

View source ↗

Summary

A Phase 3 trial (FRUTIGA) evaluating Fruquintinib plus Paclitaxel in second-line advanced gastric cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Advanced Gastric Cancer | Phase 3 | Status: COMPLETED